Sleep Aids (Pharmacies) - D-A-CH

  • D-A-CH
  • Revenue in the Sleep Aids market is projected to reach US$303.60m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.35%, resulting in a market volume of US$324.70m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,473.00m in 2024).
  • In relation to total population figures, per person revenues of US$3.00 are generated in 2024.

Key regions: United States, Germany, Australia, India, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Sleep Aids (Pharmacies) market in D-A-CH is experiencing steady growth, driven by customer preferences for natural remedies and an increasing awareness of the importance of sleep for overall health and well-being.

Customer preferences:
Customers in the D-A-CH region are increasingly seeking out natural sleep aids, such as herbal supplements and aromatherapy products. This shift in preference can be attributed to a growing awareness of the potential side effects and dependency associated with traditional sleep medications. Additionally, customers are becoming more proactive in managing their sleep issues and are willing to explore alternative solutions.

Trends in the market:
One of the key trends in the Sleep Aids (Pharmacies) market in D-A-CH is the rising demand for products that promote relaxation and stress reduction. With the fast-paced and stressful nature of modern life, many individuals struggle with falling asleep and staying asleep. As a result, there is a growing market for sleep aids that help to calm the mind and promote a sense of tranquility before bedtime. Another trend in the market is the increasing popularity of sleep tracking devices and apps. These tools allow individuals to monitor their sleep patterns and gain insights into their sleep quality. As awareness of the importance of sleep grows, more people are turning to technology to help them understand and improve their sleep habits. This trend presents opportunities for companies to develop innovative sleep aids that integrate with these tracking devices and provide personalized recommendations for better sleep.

Local special circumstances:
Germany, Austria, and Switzerland have a strong tradition of natural medicine and holistic approaches to health. This cultural preference for natural remedies extends to the Sleep Aids (Pharmacies) market, with customers in D-A-CH showing a preference for herbal and homeopathic sleep aids. This presents an opportunity for companies to develop and market products that align with these preferences.

Underlying macroeconomic factors:
The Sleep Aids (Pharmacies) market in D-A-CH is also influenced by macroeconomic factors such as the aging population and increasing stress levels. As the population ages, the prevalence of sleep disorders and insomnia increases, driving the demand for sleep aids. Additionally, the high-stress levels associated with modern lifestyles contribute to sleep disturbances, leading individuals to seek out solutions to improve their sleep quality. In conclusion, the Sleep Aids (Pharmacies) market in D-A-CH is experiencing growth due to customer preferences for natural remedies, the increasing demand for products that promote relaxation and stress reduction, and the popularity of sleep tracking devices. The cultural preference for natural medicine and the influence of macroeconomic factors such as the aging population and high stress levels further contribute to the growth of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)